Define the phenotype
- Glucose + beta-hydroxybutyrate
- Venous pH/bicarbonate + electrolytes
- Serum osmolality + mental status
- Classify DKA, isolated HHS or mixed DKA/HHS
Ketotic metabolic decompensation requiring fluid resuscitation, potassium-first insulin sequencing and continued insulin until ketoacidosis resolves—even when glucose is not markedly elevated.
Hyperglycemic crisis: distinguish DKA, HHS and overlap, then sequence potassium, fluids and insulin safely
Never start insulin before correcting severe hypokalemia, and never declare resolution from a normalized glucose value alone.
Diagnose DKA from diabetes/hyperglycemia or a compatible context plus ketonemia and metabolic acidosis. Measure beta-hydroxybutyrate directly when possible; glucose may be only mildly elevated in euglycemic DKA. Common settings include SGLT2 inhibitors, pregnancy, prolonged fasting, vomiting and partial insulin treatment.
Begin isotonic saline or balanced crystalloid with frequent reassessment of perfusion, sodium, heart/kidney function and urine output. Replace volume without assuming every patient needs the same rate or total volume.
Check potassium before insulin. If K+ is <3.5 mmol/L, replace potassium first and delay insulin until K+ is safely above that level. If potassium is not low, start insulin while monitoring for the predictable intracellular potassium shift.
Caution
Euglycemic DKA can be missed when clinicians use a high glucose threshold as a gatekeeper. Significant ketonemia plus metabolic acidosis in the right clinical setting requires DKA treatment even when glucose is near normal.
Current multinational consensus for adult DKA, euglycemic DKA and mixed DKA/HHS diagnosis and treatment.
Evidence status
Review metadata not yet recorded.
Status, review dates and guideline versions appear here once editorial metadata is authored for this content.
From primary disorder confirmation and Anion Gap calculation to Winter's compensation, delta ratio, and targeted source control.
From confirming the acid-base disorder to the anion-gap differential.
From securing the basics to categorizing structural, toxic-metabolic, infectious, and seizure-related causes.
Confirm HHS vs mixed DKA/HHS → restore volume → potassium-safe insulin → controlled osmolality correction.
Pathophysiology, SGLT2i euglycemic DKA, balanced fluid resuscitation, potassium-before-insulin safety rules, dextrose addition kinetics, and subcutaneous transition.
ICU recognition and treatment of severe hyperglycemia, hyperosmolality and dehydration with careful fluid, potassium and insulin sequencing.